nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE4A—chronic obstructive pulmonary disease	0.286	0.744	CbGaD
Pentoxifylline—PDE4A—Roflumilast—chronic obstructive pulmonary disease	0.101	0.208	CbGbCtD
Pentoxifylline—CYP1A2—chronic obstructive pulmonary disease	0.0984	0.256	CbGaD
Pentoxifylline—ADORA2B—Aminophylline—chronic obstructive pulmonary disease	0.0966	0.198	CbGbCtD
Pentoxifylline—PDE4B—Roflumilast—chronic obstructive pulmonary disease	0.0965	0.198	CbGbCtD
Pentoxifylline—ADORA1—Aminophylline—chronic obstructive pulmonary disease	0.0699	0.143	CbGbCtD
Pentoxifylline—ADORA2A—Aminophylline—chronic obstructive pulmonary disease	0.0618	0.127	CbGbCtD
Pentoxifylline—PDE4A—Aminophylline—chronic obstructive pulmonary disease	0.0555	0.114	CbGbCtD
Pentoxifylline—PDE5A—pulmonary artery—chronic obstructive pulmonary disease	0.00686	0.245	CbGeAlD
Pentoxifylline—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00658	0.0135	CbGbCtD
Pentoxifylline—NT5E—respiratory system—chronic obstructive pulmonary disease	0.00178	0.0634	CbGeAlD
Pentoxifylline—NT5E—connective tissue—chronic obstructive pulmonary disease	0.00156	0.0558	CbGeAlD
Pentoxifylline—NT5E—bronchus—chronic obstructive pulmonary disease	0.00146	0.0522	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—chronic obstructive pulmonary disease	0.00143	0.051	CbGeAlD
Pentoxifylline—NT5E—trachea—chronic obstructive pulmonary disease	0.00131	0.0468	CbGeAlD
Pentoxifylline—ADORA2B—bronchus—chronic obstructive pulmonary disease	0.00125	0.0447	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00123	0.0437	CbGeAlD
Pentoxifylline—Dyphylline—PDE4A—chronic obstructive pulmonary disease	0.00118	0.51	CrCbGaD
Pentoxifylline—PDE5A—respiratory system—chronic obstructive pulmonary disease	0.00115	0.0411	CbGeAlD
Pentoxifylline—ADORA2B—trachea—chronic obstructive pulmonary disease	0.00112	0.0401	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—chronic obstructive pulmonary disease	0.00102	0.0362	CbGeAlD
Pentoxifylline—NT5E—lung—chronic obstructive pulmonary disease	0.000944	0.0337	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000929	0.0331	CbGeAlD
Pentoxifylline—PDE4B—respiratory system—chronic obstructive pulmonary disease	0.000809	0.0288	CbGeAlD
Pentoxifylline—ADORA2B—lung—chronic obstructive pulmonary disease	0.000808	0.0288	CbGeAlD
Pentoxifylline—PDE4A—lung—chronic obstructive pulmonary disease	0.00072	0.0257	CbGeAlD
Pentoxifylline—PDE4B—bronchus—chronic obstructive pulmonary disease	0.000666	0.0237	CbGeAlD
Pentoxifylline—PDE5A—lung—chronic obstructive pulmonary disease	0.000613	0.0218	CbGeAlD
Pentoxifylline—PDE4B—trachea—chronic obstructive pulmonary disease	0.000598	0.0213	CbGeAlD
Pentoxifylline—ADORA1—lung—chronic obstructive pulmonary disease	0.000581	0.0207	CbGeAlD
Pentoxifylline—Theobromine—CYP1A2—chronic obstructive pulmonary disease	0.000551	0.239	CrCbGaD
Pentoxifylline—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000497	0.0177	CbGeAlD
Pentoxifylline—PDE4B—lung—chronic obstructive pulmonary disease	0.00043	0.0153	CbGeAlD
Pentoxifylline—Caffeine—CYP1A1—chronic obstructive pulmonary disease	0.000294	0.127	CrCbGaD
Pentoxifylline—Caffeine—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.123	CrCbGaD
Pentoxifylline—CYP1A2—lung—chronic obstructive pulmonary disease	0.000264	0.00941	CbGeAlD
Pentoxifylline—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00235	CcSEcCtD
Pentoxifylline—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00235	CcSEcCtD
Pentoxifylline—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00234	CcSEcCtD
Pentoxifylline—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00232	CcSEcCtD
Pentoxifylline—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00232	CcSEcCtD
Pentoxifylline—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00232	CcSEcCtD
Pentoxifylline—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000168	0.0023	CcSEcCtD
Pentoxifylline—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.00229	CcSEcCtD
Pentoxifylline—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00228	CcSEcCtD
Pentoxifylline—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00227	CcSEcCtD
Pentoxifylline—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00227	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00226	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00226	CcSEcCtD
Pentoxifylline—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00223	CcSEcCtD
Pentoxifylline—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00223	CcSEcCtD
Pentoxifylline—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.00223	CcSEcCtD
Pentoxifylline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00222	CcSEcCtD
Pentoxifylline—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00222	CcSEcCtD
Pentoxifylline—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00222	CcSEcCtD
Pentoxifylline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00219	CcSEcCtD
Pentoxifylline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00218	CcSEcCtD
Pentoxifylline—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00217	CcSEcCtD
Pentoxifylline—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00217	CcSEcCtD
Pentoxifylline—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00215	CcSEcCtD
Pentoxifylline—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Pentoxifylline—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00214	CcSEcCtD
Pentoxifylline—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00214	CcSEcCtD
Pentoxifylline—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00214	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Pentoxifylline—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Pentoxifylline—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Pentoxifylline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.0021	CcSEcCtD
Pentoxifylline—Infection—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00209	CcSEcCtD
Pentoxifylline—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00209	CcSEcCtD
Pentoxifylline—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00207	CcSEcCtD
Pentoxifylline—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00207	CcSEcCtD
Pentoxifylline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00207	CcSEcCtD
Pentoxifylline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Pentoxifylline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Pentoxifylline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Pentoxifylline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Pentoxifylline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Pentoxifylline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00204	CcSEcCtD
Pentoxifylline—Infection—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00204	CcSEcCtD
Pentoxifylline—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00204	CcSEcCtD
Pentoxifylline—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00204	CcSEcCtD
Pentoxifylline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00203	CcSEcCtD
Pentoxifylline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00201	CcSEcCtD
Pentoxifylline—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00201	CcSEcCtD
Pentoxifylline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000146	0.002	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00198	CcSEcCtD
Pentoxifylline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00198	CcSEcCtD
Pentoxifylline—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00197	CcSEcCtD
Pentoxifylline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00196	CcSEcCtD
Pentoxifylline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00196	CcSEcCtD
Pentoxifylline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.00195	CcSEcCtD
Pentoxifylline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00195	CcSEcCtD
Pentoxifylline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00194	CcSEcCtD
Pentoxifylline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00193	CcSEcCtD
Pentoxifylline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00192	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00192	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00191	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00191	CcSEcCtD
Pentoxifylline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000138	0.0019	CcSEcCtD
Pentoxifylline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.0019	CcSEcCtD
Pentoxifylline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00189	CcSEcCtD
Pentoxifylline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000138	0.00189	CcSEcCtD
Pentoxifylline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00188	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00187	CcSEcCtD
Pentoxifylline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Pentoxifylline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Pentoxifylline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Pentoxifylline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00187	CcSEcCtD
Pentoxifylline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00186	CcSEcCtD
Pentoxifylline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00185	CcSEcCtD
Pentoxifylline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00185	CcSEcCtD
Pentoxifylline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00185	CcSEcCtD
Pentoxifylline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.00184	CcSEcCtD
Pentoxifylline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00183	CcSEcCtD
Pentoxifylline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.00183	CcSEcCtD
Pentoxifylline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00181	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00181	CcSEcCtD
Pentoxifylline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.0018	CcSEcCtD
Pentoxifylline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000131	0.0018	CcSEcCtD
Pentoxifylline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00179	CcSEcCtD
Pentoxifylline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00177	CcSEcCtD
Pentoxifylline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00176	CcSEcCtD
Pentoxifylline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.00175	CcSEcCtD
Pentoxifylline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00175	CcSEcCtD
Pentoxifylline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00175	CcSEcCtD
Pentoxifylline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00174	CcSEcCtD
Pentoxifylline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00174	CcSEcCtD
Pentoxifylline—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Pentoxifylline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Pentoxifylline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Pentoxifylline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.00173	CcSEcCtD
Pentoxifylline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00172	CcSEcCtD
Pentoxifylline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Pentoxifylline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.0017	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00168	CcSEcCtD
Pentoxifylline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00167	CcSEcCtD
Pentoxifylline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00167	CcSEcCtD
Pentoxifylline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00166	CcSEcCtD
Pentoxifylline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00166	CcSEcCtD
Pentoxifylline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00166	CcSEcCtD
Pentoxifylline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00166	CcSEcCtD
Pentoxifylline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00166	CcSEcCtD
Pentoxifylline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.00164	CcSEcCtD
Pentoxifylline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Pentoxifylline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Pentoxifylline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Pentoxifylline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Pentoxifylline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Pentoxifylline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Pentoxifylline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00163	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00162	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00161	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.0016	CcSEcCtD
Pentoxifylline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00158	CcSEcCtD
Pentoxifylline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00157	CcSEcCtD
Pentoxifylline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00157	CcSEcCtD
Pentoxifylline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00155	CcSEcCtD
Pentoxifylline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00155	CcSEcCtD
Pentoxifylline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000113	0.00155	CcSEcCtD
Pentoxifylline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00152	CcSEcCtD
Pentoxifylline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00151	CcSEcCtD
Pentoxifylline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00151	CcSEcCtD
Pentoxifylline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00149	CcSEcCtD
Pentoxifylline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00149	CcSEcCtD
Pentoxifylline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00148	CcSEcCtD
Pentoxifylline—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00146	CcSEcCtD
Pentoxifylline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00146	CcSEcCtD
Pentoxifylline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00146	CcSEcCtD
Pentoxifylline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00144	CcSEcCtD
Pentoxifylline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00144	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00143	CcSEcCtD
Pentoxifylline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00142	CcSEcCtD
Pentoxifylline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00141	CcSEcCtD
Pentoxifylline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.0014	CcSEcCtD
Pentoxifylline—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00139	CcSEcCtD
Pentoxifylline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00139	CcSEcCtD
Pentoxifylline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00139	CcSEcCtD
Pentoxifylline—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.91e-05	0.00136	CcSEcCtD
Pentoxifylline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.89e-05	0.00136	CcSEcCtD
Pentoxifylline—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.73e-05	0.00134	CcSEcCtD
Pentoxifylline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.73e-05	0.00134	CcSEcCtD
Pentoxifylline—Rash—Arformoterol—chronic obstructive pulmonary disease	9.65e-05	0.00132	CcSEcCtD
Pentoxifylline—Rash—Formoterol—chronic obstructive pulmonary disease	9.65e-05	0.00132	CcSEcCtD
Pentoxifylline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.64e-05	0.00132	CcSEcCtD
Pentoxifylline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.64e-05	0.00132	CcSEcCtD
Pentoxifylline—Headache—Arformoterol—chronic obstructive pulmonary disease	9.59e-05	0.00132	CcSEcCtD
Pentoxifylline—Headache—Formoterol—chronic obstructive pulmonary disease	9.59e-05	0.00132	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	9.57e-05	0.00131	CcSEcCtD
Pentoxifylline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.56e-05	0.00131	CcSEcCtD
Pentoxifylline—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.53e-05	0.00131	CcSEcCtD
Pentoxifylline—Rash—Montelukast—chronic obstructive pulmonary disease	9.45e-05	0.0013	CcSEcCtD
Pentoxifylline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.0013	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.42e-05	0.00129	CcSEcCtD
Pentoxifylline—Headache—Montelukast—chronic obstructive pulmonary disease	9.39e-05	0.00129	CcSEcCtD
Pentoxifylline—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.28e-05	0.00127	CcSEcCtD
Pentoxifylline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.19e-05	0.00126	CcSEcCtD
Pentoxifylline—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.00126	CcSEcCtD
Pentoxifylline—Rash—Salbutamol—chronic obstructive pulmonary disease	9.11e-05	0.00125	CcSEcCtD
Pentoxifylline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.11e-05	0.00125	CcSEcCtD
Pentoxifylline—Nausea—Formoterol—chronic obstructive pulmonary disease	9.09e-05	0.00125	CcSEcCtD
Pentoxifylline—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.09e-05	0.00125	CcSEcCtD
Pentoxifylline—Headache—Salbutamol—chronic obstructive pulmonary disease	9.05e-05	0.00124	CcSEcCtD
Pentoxifylline—Nausea—Montelukast—chronic obstructive pulmonary disease	8.91e-05	0.00122	CcSEcCtD
Pentoxifylline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.8e-05	0.00121	CcSEcCtD
Pentoxifylline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.0012	CcSEcCtD
Pentoxifylline—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.59e-05	0.00118	CcSEcCtD
Pentoxifylline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.54e-05	0.00117	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.00117	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.00116	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.00114	CcSEcCtD
Pentoxifylline—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.00114	CcSEcCtD
Pentoxifylline—Shock—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.00112	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.09e-05	0.00111	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.01e-05	0.0011	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.00108	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.00105	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.00104	CcSEcCtD
Pentoxifylline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.5e-05	0.00103	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.00101	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000955	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.00094	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.83e-05	0.000938	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000936	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000931	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000926	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000913	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.59e-05	0.000904	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000878	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000875	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000862	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000859	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000856	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000852	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000838	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000827	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000827	CcSEcCtD
Pentoxifylline—Infection—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000821	CcSEcCtD
Pentoxifylline—Shock—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000813	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000807	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000803	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000799	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000788	CcSEcCtD
Pentoxifylline—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.0023	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	5.5e-05	0.00227	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.49e-05	0.000753	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.48e-05	0.000752	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—NOS2—chronic obstructive pulmonary disease	5.45e-05	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.45e-05	0.00225	CbGpPWpGaD
Pentoxifylline—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000748	CcSEcCtD
Pentoxifylline—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	5.44e-05	0.00224	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.41e-05	0.00223	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	5.39e-05	0.00222	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CTGF—chronic obstructive pulmonary disease	5.39e-05	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.37e-05	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	5.36e-05	0.00221	CbGpPWpGaD
Pentoxifylline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000728	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.24e-05	0.00216	CbGpPWpGaD
Pentoxifylline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000719	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—chronic obstructive pulmonary disease	5.23e-05	0.000717	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000717	CcSEcCtD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.00215	CbGpPWpGaD
Pentoxifylline—Headache—Prednisolone—chronic obstructive pulmonary disease	5.19e-05	0.000713	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.18e-05	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.18e-05	0.00214	CbGpPWpGaD
Pentoxifylline—Constipation—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000707	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.15e-05	0.00212	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.12e-05	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.11e-05	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	5e-05	0.00206	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000681	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.96e-05	0.00205	CbGpPWpGaD
Pentoxifylline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.000676	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.92e-05	0.000676	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.91e-05	0.00203	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.91e-05	0.00203	CbGpPWpGaD
Pentoxifylline—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000657	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000654	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000654	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.75e-05	0.00196	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.72e-05	0.00195	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.7e-05	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.63e-05	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.6e-05	0.0019	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.59e-05	0.00189	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—ALB—chronic obstructive pulmonary disease	4.58e-05	0.00189	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.56e-05	0.00188	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.55e-05	0.00187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	4.52e-05	0.00186	CbGpPWpGaD
Pentoxifylline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.51e-05	0.00186	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.46e-05	0.00184	CbGpPWpGaD
Pentoxifylline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.00184	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000609	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.41e-05	0.00182	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.38e-05	0.00181	CbGpPWpGaD
Pentoxifylline—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.32e-05	0.000593	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.31e-05	0.00178	CbGpPWpGaD
Pentoxifylline—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.000585	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.21e-05	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.18e-05	0.00172	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.14e-05	0.00171	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.13e-05	0.0017	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.12e-05	0.000566	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.08e-05	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.07e-05	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.05e-05	0.00167	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.04e-05	0.00167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4e-05	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.99e-05	0.00165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.99e-05	0.00165	CbGpPWpGaD
Pentoxifylline—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.000547	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.94e-05	0.00163	CbGpPWpGaD
Pentoxifylline—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000526	CcSEcCtD
Pentoxifylline—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.00157	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.81e-05	0.00157	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.8e-05	0.00157	CbGpPWpGaD
Pentoxifylline—Rash—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000521	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000521	CcSEcCtD
Pentoxifylline—Headache—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000518	CcSEcCtD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.00151	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.61e-05	0.00149	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.6e-05	0.00149	CbGpPWpGaD
Pentoxifylline—Nausea—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.000491	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.55e-05	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.52e-05	0.00145	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.5e-05	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.0014	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.24e-05	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.23e-05	0.00133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.22e-05	0.00133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.18e-05	0.00131	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.16e-05	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	3.15e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.00129	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.09e-05	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.08e-05	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.08e-05	0.00127	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.08e-05	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.06e-05	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.03e-05	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.9e-05	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.9e-05	0.0012	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.9e-05	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.89e-05	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.85e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.83e-05	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.8e-05	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.75e-05	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.75e-05	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.64e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.00108	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.61e-05	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.59e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.59e-05	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.58e-05	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	2.55e-05	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.55e-05	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.5e-05	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.5e-05	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.47e-05	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.00102	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—chronic obstructive pulmonary disease	2.45e-05	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.44e-05	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.41e-05	0.000994	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.41e-05	0.000994	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.4e-05	0.00099	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—chronic obstructive pulmonary disease	2.39e-05	0.000984	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.36e-05	0.000975	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.35e-05	0.00097	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.35e-05	0.00097	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—chronic obstructive pulmonary disease	2.34e-05	0.000967	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.000966	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.000955	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.26e-05	0.000933	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.26e-05	0.000931	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.24e-05	0.000924	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.24e-05	0.000924	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.00092	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.23e-05	0.00092	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.23e-05	0.000919	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.2e-05	0.000907	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.19e-05	0.000902	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.19e-05	0.000902	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.12e-05	0.000875	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.05e-05	0.000845	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.000845	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.000835	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.02e-05	0.000835	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.02e-05	0.000834	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2e-05	0.000826	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.99e-05	0.000821	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.97e-05	0.000814	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.00081	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	1.96e-05	0.00081	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000801	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.93e-05	0.000795	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.00079	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.91e-05	0.000786	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.9e-05	0.000785	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.000751	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.81e-05	0.000746	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.8e-05	0.000744	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.79e-05	0.000739	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.78e-05	0.000735	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.74e-05	0.000718	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.68e-05	0.000692	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.66e-05	0.000684	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.000682	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000676	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.000671	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.58e-05	0.000652	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.56e-05	0.000645	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.55e-05	0.000639	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.53e-05	0.000631	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.51e-05	0.000623	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.49e-05	0.000614	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.49e-05	0.000614	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.48e-05	0.00061	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.48e-05	0.000609	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.000587	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000575	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.39e-05	0.000575	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.38e-05	0.000571	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.38e-05	0.000568	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.000564	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.000558	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.34e-05	0.000554	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.32e-05	0.000546	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.3e-05	0.000534	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000533	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000522	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.26e-05	0.000519	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000516	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.24e-05	0.000513	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.000499	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.2e-05	0.000496	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000493	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.2e-05	0.000493	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.13e-05	0.000464	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.00046	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.11e-05	0.000459	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.09e-05	0.000449	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000444	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000441	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.04e-05	0.000428	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.04e-05	0.000427	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.01e-05	0.000415	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.91e-06	0.000409	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.88e-06	0.000408	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.77e-06	0.000403	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.71e-06	0.0004	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.43e-06	0.000389	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.36e-06	0.000386	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.35e-06	0.000385	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.25e-06	0.000382	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.14e-06	0.000377	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9e-06	0.000371	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.83e-06	0.000364	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.79e-06	0.000363	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.72e-06	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.69e-06	0.000358	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.43e-06	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.36e-06	0.000345	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.33e-06	0.000344	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.99e-06	0.000329	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.95e-06	0.000328	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.59e-06	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.48e-06	0.000308	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.46e-06	0.000308	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.39e-06	0.000305	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.22e-06	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.14e-06	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.14e-06	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.11e-06	0.000293	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.03e-06	0.00029	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.82e-06	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.76e-06	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.68e-06	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.56e-06	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.51e-06	0.000268	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.49e-06	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.43e-06	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.07e-06	0.00025	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6e-06	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.95e-06	0.000246	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.84e-06	0.000241	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.77e-06	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.57e-06	0.00023	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.51e-06	0.000227	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.5e-06	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.49e-06	0.000226	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.47e-06	0.000225	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.44e-06	0.000224	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.4e-06	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.4e-06	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.22e-06	0.000215	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.07e-06	0.000209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.96e-06	0.000205	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.94e-06	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.9e-06	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.69e-06	0.000193	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.59e-06	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.53e-06	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.49e-06	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.3e-06	0.000178	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.22e-06	0.000174	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.2e-06	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.15e-06	0.000171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.81e-06	0.000157	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.76e-06	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.54e-06	0.000146	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.5e-06	0.000145	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.32e-06	0.000137	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.24e-06	0.000134	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.26e-06	9.31e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.16e-06	8.91e-05	CbGpPWpGaD
